These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26358867)

  • 1. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Th17 cells in autoimmune diseases.
    Yang J; Sundrud MS; Skepner J; Yamagata T
    Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y; Shen F; Crellin NK; Ouyang W
    Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
    Zhu S; Qian Y
    Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells.
    Singh B; Schwartz JA; Sandrock C; Bellemore SM; Nikoopour E
    Indian J Med Res; 2013 Nov; 138(5):591-4. PubMed ID: 24434314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24.
    Chong WP; Mattapallil MJ; Raychaudhuri K; Bing SJ; Wu S; Zhong Y; Wang W; Chen Z; Silver PB; Jittayasothorn Y; Chan CC; Chen J; Horai R; Caspi RR
    Immunity; 2020 Aug; 53(2):384-397.e5. PubMed ID: 32673565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU).
    Sun D; Liang D; Kaplan HJ; Shao H
    Cytokine; 2015 Jul; 74(1):76-80. PubMed ID: 25742774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice.
    Shiomi A; Usui T; Ishikawa Y; Shimizu M; Murakami K; Mimori T
    J Immunol; 2014 Jul; 193(2):849-59. PubMed ID: 24951817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases.
    Tabarkiewicz J; Pogoda K; Karczmarczyk A; Pozarowski P; Giannopoulos K
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):435-49. PubMed ID: 26062902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
    Roeleveld DM; Koenders MI
    Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17: a new actor in IFN-driven systemic autoimmune diseases.
    Ambrosi A; Espinosa A; Wahren-Herlenius M
    Eur J Immunol; 2012 Sep; 42(9):2274-84. PubMed ID: 22949326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting IL-17 and IL-23 in Immune Mediated Renal Disease.
    Ghali JR; Holdsworth SR; Kitching AR
    Curr Med Chem; 2015; 22(38):4341-65. PubMed ID: 26521930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.
    Qu N; Xu M; Mizoguchi I; Furusawa J; Kaneko K; Watanabe K; Mizuguchi J; Itoh M; Kawakami Y; Yoshimoto T
    Clin Dev Immunol; 2013; 2013():968549. PubMed ID: 23956763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
    van Hamburg JP; Tas SW
    J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
    Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
    Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.